Retatrutide 10mg is the smallest pen format on the UK research market, and it is the one buyers ask about most before realising it is rarely the sensible choice. This guide sets out exactly what a retatrutide 10mg pen contains, how its cost per milligram compares with the 20mg and 40mg formats, how far it stretches against published trial schedules, how to read the label without being misled, and the narrow case where the smaller pen genuinely makes sense. Retatrutide holds no UK marketing authorisation and everything supplied here is for laboratory and research use only.
Table of Contents
Retatrutide 10mg at a Glance
Before the detail, here is the whole format summarised in one table. Every figure below is drawn from UK research supplier listings observed across 2026, not from manufacturer marketing.
| Detail | Retatrutide 10mg |
|---|---|
| Total content | 10mg of retatrutide per pen |
| Typical UK price | £80 to £110 |
| Cost per mg | £8.00 to £11.00 |
| Format | Pre filled dial dosing pen, solution not powder |
| Common dial increments | 0.25mg to 1mg per click depending on device |
| Storage | Refrigerate 2 to 8 degrees, never freeze |
| UK availability | Limited, most suppliers start at 20mg |
| Classification | Research use only, not for human consumption |
The number that matters in that table is the third row. At £8 to £11 per milligram, retatrutide 10mg is the single most expensive way to buy this compound in the United Kingdom, roughly double the per milligram cost of a 40mg kit bought from the same supplier on the same day.

Why 10mg Is Usually Poor Value
Peptide pricing does not scale linearly with content, and that single fact explains almost everything about the retatrutide 10mg format. A large share of the delivered cost sits in the device, the sterile fill process, the refrigerated logistics and the packaging rather than in the compound itself. A pen holding a quarter of the material does not cost a quarter as much to produce, ship or store, so the fixed costs are spread across fewer milligrams and the per milligram figure climbs.
The consequence is straightforward. Buying retatrutide 10mg twice costs meaningfully more than buying a single 20mg pen, for identical total material, twice the shipping exposure and twice the cold chain risk. Anyone budgeting across several months of work feels that difference immediately. The full market picture across every format and brand sits in our retatrutide price UK guide, which is the only open UK cost per milligram index we are aware of.
There is a second, less obvious penalty. Because the 10mg format is uncommon, the suppliers who stock it tend to be the ones targeting first time buyers on headline price. That is exactly the segment where underdosed and substituted product concentrates, so the smallest pen carries a slightly worse average quality profile as well as a worse price.
10mg, 20mg and 40mg Compared
Set the three formats side by side and the hierarchy is unambiguous.
| Format | Typical UK price | Cost per mg | Deliveries per 40mg | Verdict |
|---|---|---|---|---|
| Retatrutide 10mg | £80 to £110 | £8.00 to £11.00 | 4 | Most expensive per mg, scarce stock |
| Retatrutide 20mg | £120 to £180 | £6.00 to £9.00 | 2 | Sensible first order |
| Retatrutide 40mg | £180 to £260 | £4.50 to £6.50 | 1 | Best value, fewest deliveries |
Across the same total quantity, choosing 10mg pens instead of a single 40mg kit costs roughly £100 to £180 more and puts the material through four separate transit cycles rather than one. Our own range skips the format for exactly this reason and starts at the 20mg pen at £139.99, with the 40mg kit at £220 working out at £5.50 per milligram. Browse everything in stock on the full shop.
How Long a Retatrutide 10mg Pen Lasts
Mapping a retatrutide 10mg pen onto the published trial schedules makes the practical limits obvious. At the 2mg weekly amount used early in the Phase 2 escalation, 10mg covers five weeks. At 4mg weekly it covers two and a half weeks. At the 8mg amount studied in the upper arms it covers barely more than a week, and at 12mg weekly a single pen does not complete one month.
| Weekly amount | Weeks covered by 10mg | Weeks covered by 20mg | Weeks covered by 40mg |
|---|---|---|---|
| 1mg | 10 | 20 | 40 |
| 2mg | 5 | 10 | 20 |
| 4mg | 2.5 | 5 | 10 |
| 8mg | 1.25 | 2.5 | 5 |
| 12mg | 0.83 | 1.67 | 3.3 |
Read down the first column and the pattern is clear. The smallest pen only spans a meaningful period at the very lowest end of the studied range, which is precisely the phase where a research protocol is least likely to stop. That mismatch is the practical reason experienced buyers skip it.
Where 10mg Sits Against the Trial Amounts
No trial arm used a flat 10mg weekly amount. The Phase 2 obesity study published in the New England Journal of Medicine randomised participants to target amounts of 1mg, 4mg, 8mg and 12mg weekly, every one of them reached through stepped escalation rather than started at target. The ongoing Phase 3 TRIUMPH programme registered on ClinicalTrials.gov follows the same escalation logic.
So retatrutide 10mg is a supply format, not a protocol figure. Anyone treating the pen size as a dosing recommendation has misread what the number on the box refers to, and that misreading is common enough that some suppliers quietly encourage it. The complete published schedules, escalation intervals and the reported discontinuation rates sit in our retatrutide dosage chart guide.
Reading a Retatrutide 10mg Label Properly
A retatrutide 10mg label should tell you five things without ambiguity. If any one is missing, treat the listing as unverified rather than assuming an oversight.
- Strength printed on the device, not only in the web listing. A pen whose strength appears only on the product page cannot be checked once the box is discarded.
- Fill volume and concentration, so that total content can be confirmed arithmetically rather than taken on trust.
- Batch or lot number that matches the certificate of analysis, if one is supplied.
- A research use only statement on the product itself. Its absence is a compliance red flag, not a design choice.
- Storage conditions stated in degrees, not as a vague instruction to keep cool.
The single most useful check is the arithmetic one. Multiply stated concentration by stated volume and confirm it equals 10mg. Listings that give one figure but not the other are the ones worth walking away from.
The Price Floor Test for Small Pens
Synthesis, purification, sterile fill and refrigerated handling impose a hard cost floor on any genuine peptide. That floor does not disappear because a pen is small. A retatrutide 10mg pen advertised at £25 or £30 is not a bargain on a real product, it is arithmetic telling you the contents do not match the label.
Use a simple screen. Divide the asking price by the stated milligrams. Anything landing below roughly £3 per milligram for retatrutide sits under the plausible production floor for the UK market, and the most common explanations are underfill, a substituted cheaper peptide, or no active compound at all. The MHRA seized roughly 20 million doses of illegal weight loss medicines in 2025, which is the scale of the counterfeit problem this test is protecting you from.
Handling and Storing a Retatrutide 10mg Pen
Cold chain handling decides whether a peptide matches its label far more reliably than branding does, and a small pen offers no protection from that.
- Refrigerate between 2 and 8 degrees on arrival and never freeze the pen, since freezing denatures the peptide as surely as heat degrades it.
- Keep it in the original box and away from direct light, which accelerates degradation in solution.
- Avoid repeated temperature cycling. Several small excursions do more damage than one stable period slightly out of range.
- Record batch details and arrival condition in your research log the day it arrives, not later from memory.
- Never accept a delivery that arrives warm on the assumption that refrigerating it afterwards reverses anything. It does not.
Brands Selling the 10mg Format in the UK
Three brand names come up repeatedly around the smaller format in the UK. VLS and Viogen both list pen products in the 10mg and 20mg range, and various unbranded white label pens circulate at the cheaper end. Brand recognition is a weak quality signal in this market because packaging is trivially copied, so treat a familiar name as a starting point rather than as verification. The checks that actually separate suppliers, including batch documentation, cold chain policy and whether the compliance line is stated openly, are set out in our buyer guide.
Five Mistakes Buyers Make With the 10mg Format
These five recur constantly in questions we receive about the smallest format.
- Treating the pen size as a dose. 10mg is total content, not a weekly amount, and no trial arm used it as one.
- Comparing headline prices rather than cost per milligram. An £89 pen looks cheaper than a £220 kit and is far more expensive per unit of material.
- Buying small repeatedly to spread cost. Four deliveries means four cold chain exposures and roughly £150 wasted against a single kit.
- Assuming a small pen is a trial size from the manufacturer. It is a supplier packaging decision, nothing more.
- Ignoring the price floor. The cheapest 10mg listings are cheap because of what is or is not inside them.
Which Strength to Choose
Retatrutide 10mg makes sense in one narrow case: a short pilot where you want the smallest possible quantity on hand and cost per milligram genuinely does not matter to you. For anything longer than a few weeks, the 20mg pen is the sensible entry point and the 40mg kit is the clear value choice.
If you are still deciding between formats, the dial mechanics, fill volumes and device differences are compared in the retatrutide pen guide, the compound itself is explained in the reta peptide guide, and the ordering checks worth running before any purchase are in the buy retatrutide UK guide.

Legal Position in the United Kingdom
Retatrutide holds no marketing authorisation from the MHRA. It is not a licensed medicine in the United Kingdom, it cannot lawfully be supplied for human use, and it cannot be advertised with therapeutic claims. Every product we list, including every pen strength, is supplied for laboratory research use only and is not for human or veterinary consumption.
Anyone seeking treatment for obesity or type 2 diabetes should speak to a registered UK prescriber about licensed options rather than sourcing an unlicensed compound. Nothing on this page is medical advice, and no strength of retatrutide should be read as a treatment recommendation.
Retatrutide 10mg FAQ
How much does retatrutide 10mg cost in the UK?
Typically £80 to £110 per pen, which works out at £8.00 to £11.00 per milligram. That is the most expensive per milligram format on the UK market.
Is retatrutide 10mg better value than 20mg?
No. A 20mg pen runs about £6.00 to £9.00 per milligram and a 40mg kit £4.50 to £6.50, so both beat the smallest format on value by a wide margin.
How long does a retatrutide 10mg pen last?
Against published trial schedules it covers about five weeks at the 2mg amount, two and a half weeks at 4mg, and just over a week at the 8mg amount studied in the upper trial arms.
Was 10mg used in the retatrutide trials?
No. The Phase 2 obesity study used target amounts of 1mg, 4mg, 8mg and 12mg weekly, all reached by stepped escalation. 10mg is a pen size, not a protocol amount.
Do you sell retatrutide 10mg?
No. We start at 20mg because the smallest format carries a structural per milligram penalty and scarcer supply without any offsetting benefit.
How should a retatrutide 10mg pen be stored?
Refrigerated between 2 and 8 degrees, never frozen, kept in the original packaging away from direct light, and never left to cycle in and out of temperature.
Why is a cheap retatrutide 10mg pen a warning sign?
Production, purification and refrigerated handling impose a hard cost floor. A price far below roughly £3 per milligram usually means underfill, a substituted peptide, or no active compound.
Is retatrutide legal to buy in the UK?
It can be supplied for laboratory research use only. It holds no MHRA authorisation, is not a licensed medicine, and cannot lawfully be sold or supplied for human use.
